Cargando…

Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly

OBJECTIVE: This study aimed to evaluate Ebstein’s anomaly surgical correction and its early and long-term outcomes. METHODS: A retrospective analysis of 62 consecutive patients who underwent surgical repair of Ebstein’s anomaly in our institution from January 2000 to July 2016. The following long-te...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Guilherme Viotto Rodrigues, Miana, Leonardo Augusto, Caneo, Luiz Fernando, Turquetto, Aída Luiza Ribeiro, Tanamati, Carla, Penha, Juliano G., Jatene, Fabio B, Jatene, Marcelo B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cirurgia Cardiovascular 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852467/
https://www.ncbi.nlm.nih.gov/pubmed/31364344
http://dx.doi.org/10.21470/1678-9741-2018-0333
_version_ 1783469843872219136
author da Silva, Guilherme Viotto Rodrigues
Miana, Leonardo Augusto
Caneo, Luiz Fernando
Turquetto, Aída Luiza Ribeiro
Tanamati, Carla
Penha, Juliano G.
Jatene, Fabio B
Jatene, Marcelo B
author_facet da Silva, Guilherme Viotto Rodrigues
Miana, Leonardo Augusto
Caneo, Luiz Fernando
Turquetto, Aída Luiza Ribeiro
Tanamati, Carla
Penha, Juliano G.
Jatene, Fabio B
Jatene, Marcelo B
author_sort da Silva, Guilherme Viotto Rodrigues
collection PubMed
description OBJECTIVE: This study aimed to evaluate Ebstein’s anomaly surgical correction and its early and long-term outcomes. METHODS: A retrospective analysis of 62 consecutive patients who underwent surgical repair of Ebstein’s anomaly in our institution from January 2000 to July 2016. The following long-term outcomes were evaluated: survival, reoperations, tricuspid regurgitation, and postoperative right ventricular dysfunction. RESULTS: Valve repair was performed in 46 (74.2%) patients - 12 of them using the Da Silva cone reconstruction; tricuspid valve replacement was performed in 11 (17.7%) patients; univentricular palliation in one (1.6%) patient; and the one and a half ventricle repair in four (6.5%) patients. The patients’ mean age at the time of surgery was 20.5±14.9 years, and 46.8% of them were male. The mean follow-up time was 8.8±6 years. The 30-day mortality rate was 8.06% and the one and 10-year survival rates were 91.9% both. Eleven (17.7%) of the 62 patients required late reoperation due to tricuspid regurgitation, in an average time of 7.1±4.9 years after the first procedure. CONCLUSION: In our experience, the long-term results of the surgical treatment of Ebstein's anomaly demonstrate an acceptable survival rate and a low incidence of reinterventions.
format Online
Article
Text
id pubmed-6852467
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedade Brasileira de Cirurgia Cardiovascular
record_format MEDLINE/PubMed
spelling pubmed-68524672019-11-15 Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly da Silva, Guilherme Viotto Rodrigues Miana, Leonardo Augusto Caneo, Luiz Fernando Turquetto, Aída Luiza Ribeiro Tanamati, Carla Penha, Juliano G. Jatene, Fabio B Jatene, Marcelo B Braz J Cardiovasc Surg Original Article OBJECTIVE: This study aimed to evaluate Ebstein’s anomaly surgical correction and its early and long-term outcomes. METHODS: A retrospective analysis of 62 consecutive patients who underwent surgical repair of Ebstein’s anomaly in our institution from January 2000 to July 2016. The following long-term outcomes were evaluated: survival, reoperations, tricuspid regurgitation, and postoperative right ventricular dysfunction. RESULTS: Valve repair was performed in 46 (74.2%) patients - 12 of them using the Da Silva cone reconstruction; tricuspid valve replacement was performed in 11 (17.7%) patients; univentricular palliation in one (1.6%) patient; and the one and a half ventricle repair in four (6.5%) patients. The patients’ mean age at the time of surgery was 20.5±14.9 years, and 46.8% of them were male. The mean follow-up time was 8.8±6 years. The 30-day mortality rate was 8.06% and the one and 10-year survival rates were 91.9% both. Eleven (17.7%) of the 62 patients required late reoperation due to tricuspid regurgitation, in an average time of 7.1±4.9 years after the first procedure. CONCLUSION: In our experience, the long-term results of the surgical treatment of Ebstein's anomaly demonstrate an acceptable survival rate and a low incidence of reinterventions. Sociedade Brasileira de Cirurgia Cardiovascular 2019 /pmc/articles/PMC6852467/ /pubmed/31364344 http://dx.doi.org/10.21470/1678-9741-2018-0333 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
da Silva, Guilherme Viotto Rodrigues
Miana, Leonardo Augusto
Caneo, Luiz Fernando
Turquetto, Aída Luiza Ribeiro
Tanamati, Carla
Penha, Juliano G.
Jatene, Fabio B
Jatene, Marcelo B
Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
title Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
title_full Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
title_fullStr Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
title_full_unstemmed Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
title_short Early and Long-Term Outcomes of Surgical Treatment of Ebstein’s Anomaly
title_sort early and long-term outcomes of surgical treatment of ebstein’s anomaly
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852467/
https://www.ncbi.nlm.nih.gov/pubmed/31364344
http://dx.doi.org/10.21470/1678-9741-2018-0333
work_keys_str_mv AT dasilvaguilhermeviottorodrigues earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT mianaleonardoaugusto earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT caneoluizfernando earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT turquettoaidaluizaribeiro earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT tanamaticarla earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT penhajulianog earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT jatenefabiob earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly
AT jatenemarcelob earlyandlongtermoutcomesofsurgicaltreatmentofebsteinsanomaly